Author
Listed:
- Melanie Kolz
- Toby Johnson
- Serena Sanna
- Alexander Teumer
- Veronique Vitart
- Markus Perola
- Massimo Mangino
- Eva Albrecht
- Chris Wallace
- Martin Farrall
- Åsa Johansson
- Dale R Nyholt
- Yurii Aulchenko
- Jacques S Beckmann
- Sven Bergmann
- Murielle Bochud
- Morris Brown
- Harry Campbell
- for the EUROSPAN Consortium
- John Connell
- Anna Dominiczak
- Georg Homuth
- Claudia Lamina
- Mark I McCarthy
- for the ENGAGE Consortium
- Thomas Meitinger
- Vincent Mooser
- Patricia Munroe
- Matthias Nauck
- John Peden
- Holger Prokisch
- Perttu Salo
- Veikko Salomaa
- Nilesh J Samani
- David Schlessinger
- Manuela Uda
- Uwe Völker
- Gérard Waeber
- Dawn Waterworth
- Rui Wang-Sattler
- Alan F Wright
- Jerzy Adamski
- John B Whitfield
- Ulf Gyllensten
- James F Wilson
- Igor Rudan
- Peter Pramstaller
- Hugh Watkins
- for the PROCARDIS Consortium
- Angela Doering
- H-Erich Wichmann
- for the KORA Study
- Tim D Spector
- Leena Peltonen
- Henry Völzke
- Ramaiah Nagaraja
- Peter Vollenweider
- Mark Caulfield
- for the WTCCC
- Thomas Illig
- Christian Gieger
Abstract
Elevated serum uric acid levels cause gout and are a risk factor for cardiovascular disease and diabetes. To investigate the polygenetic basis of serum uric acid levels, we conducted a meta-analysis of genome-wide association scans from 14 studies totalling 28,141 participants of European descent, resulting in identification of 954 SNPs distributed across nine loci that exceeded the threshold of genome-wide significance, five of which are novel. Overall, the common variants associated with serum uric acid levels fall in the following nine regions: SLC2A9 (p = 5.2×10−201), ABCG2 (p = 3.1×10−26), SLC17A1 (p = 3.0×10−14), SLC22A11 (p = 6.7×10−14), SLC22A12 (p = 2.0×10−9), SLC16A9 (p = 1.1×10−8), GCKR (p = 1.4×10−9), LRRC16A (p = 8.5×10−9), and near PDZK1 (p = 2.7×10−9). Identified variants were analyzed for gender differences. We found that the minor allele for rs734553 in SLC2A9 has greater influence in lowering uric acid levels in women and the minor allele of rs2231142 in ABCG2 elevates uric acid levels more strongly in men compared to women. To further characterize the identified variants, we analyzed their association with a panel of metabolites. rs12356193 within SLC16A9 was associated with DL-carnitine (p = 4.0×10−26) and propionyl-L-carnitine (p = 5.0×10−8) concentrations, which in turn were associated with serum UA levels (p = 1.4×10−57 and p = 8.1×10−54, respectively), forming a triangle between SNP, metabolites, and UA levels. Taken together, these associations highlight additional pathways that are important in the regulation of serum uric acid levels and point toward novel potential targets for pharmacological intervention to prevent or treat hyperuricemia. In addition, these findings strongly support the hypothesis that transport proteins are key in regulating serum uric acid levels.Author Summary: Elevated serum uric acid levels cause gout and are a risk factor for cardiovascular disease and diabetes. The regulation of serum uric acid levels is under a strong genetic control. This study describes the first meta-analysis of genome-wide association scans from 14 studies totalling 28,141 participants of European descent. We show that common DNA variants at nine different loci are associated with uric acid concentrations, five of which are novel. These variants are located within the genes coding for organic anion transporter 4 (SLC22A11), monocarboxylic acid transporter 9 (SLC16A9), glucokinase regulatory protein (GCKR), Carmil (LRRC16A), and near PDZ domain-containing 1 (PDZK1). Gender-specific effects are shown for variants within the recently identified genes coding for glucose transporter 9 (SLC2A9) and the ATP-binding cassette transporter (ABCG2). Based on screening of 163 metabolites, we show an association of one of the identified variants within SLC16A9 with DL-carnitine and propionyl-L-carnitine. Moreover, DL-carnitine and propionyl-L-carnitine were strongly correlated with serum UA levels, forming a triangle between SNP, metabolites and UA levels. Taken together, these associations highlight pathways that are important in the regulation of serum uric acid levels and point toward novel potential targets for pharmacological intervention to prevent or treat hyperuricemia.
Suggested Citation
Melanie Kolz & Toby Johnson & Serena Sanna & Alexander Teumer & Veronique Vitart & Markus Perola & Massimo Mangino & Eva Albrecht & Chris Wallace & Martin Farrall & Åsa Johansson & Dale R Nyholt & Yur, 2009.
"Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations,"
PLOS Genetics, Public Library of Science, vol. 5(6), pages 1-10, June.
Handle:
RePEc:plo:pgen00:1000504
DOI: 10.1371/journal.pgen.1000504
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Rehan Qayyum & Beverly M Snively & Elad Ziv & Michael A Nalls & Yongmei Liu & Weihong Tang & Lisa R Yanek & Leslie Lange & Michele K Evans & Santhi Ganesh & Melissa A Austin & Guillaume Lettre & Diane, 2012.
"A Meta-Analysis and Genome-Wide Association Study of Platelet Count and Mean Platelet Volume in African Americans,"
PLOS Genetics, Public Library of Science, vol. 8(3), pages 1-11, March.
- Tamuno Alfred & Yoav Ben-Shlomo & Rachel Cooper & Rebecca Hardy & Ian J Deary & Jane Elliott & Sarah E Harris & Mika Kivimaki & Meena Kumari & Chris Power & John M Starr & Diana Kuh & Ian N M Day & th, 2013.
"Associations between a Polymorphism in the Pleiotropic GCKR and Age-Related Phenotypes: The HALCyon Programme,"
PLOS ONE, Public Library of Science, vol. 8(7), pages 1-9, July.
- Klaus Stark & Wibke Reinhard & Martina Grassl & Jeanette Erdmann & Heribert Schunkert & Thomas Illig & Christian Hengstenberg, 2009.
"Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease,"
PLOS ONE, Public Library of Science, vol. 4(11), pages 1-7, November.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pgen00:1000504. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosgenetics (email available below). General contact details of provider: https://journals.plos.org/plosgenetics/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.